Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 6/20 | 0.33 |
| ▸ | FNTB | P49356 | 6/20 | 0.33 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.33 |
| ▸ | UBE2N | P61088 | 1/20 | 0.33 |
| ▸ | TRHR | P34981 | 3/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | PPID | Q08752 | 2/20 | 0.31 |
| ▸ | PPIG | Q13427 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7434285 | 0.92 | TRHR (0.37) | UBE2NTRHR | |
| SCHEMBL7434279 | 0.92 | TRHR (0.37) | UBE2NTRHR | |
| SCHEMBL7280342 | 0.89 | UBE2N (0.33) | FNTAFNTBPGGT1BUBE2NTRHR | |
| SCHEMBL7273365 | 0.86 | ACE (0.34) | TRHRKMT2A | |
| SCHEMBL7434822 | 0.85 | NPSR1 (0.42) | FNTAFNTBPGGT1BUBE2NMEN1 | |
| SCHEMBL7274290 | 0.84 | FNTA (0.34) | FNTAFNTBPGGT1BUBE2NMEN1 | |
| SCHEMBL7271494 | 0.84 | TRHR (0.47) | TRHR | |
| SCHEMBL7274298 | 0.84 | FNTA (0.34) | FNTAFNTBPGGT1BUBE2NMEN1 | |
| SCHEMBL7433790 | 0.82 | UBE2N (0.38) | FNTAFNTBPGGT1BUBE2NTRHR | |
| SCHEMBL7433784 | 0.82 | UBE2N (0.38) | FNTAFNTBPGGT1BUBE2NTRHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0473993-B1 | Novel peptide derivatives and their pharmaceutical use | JAPAN TOBACCO INC (JP) | 1996-04-17 | — | — | EP | disclosed |
| US-5151497-A | Central nervous system disorders, antidepressants, epilepsy and cognition activators | JAPAN TOBACCO INC. (JP) | 1992-09-29 | — | — | US | disclosed |
| EP-0473993-A2 | Novel peptide derivatives and their pharmaceutical use | Japan Tobacco Inc. (JP) | 1992-03-11 | — | — | EP | disclosed |